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ABSTRACT 
A method of enhancing the tenderness of meat for animal or 
human consumption by treatment of pre-rigor muscle with 
the compositions of the invention. It has been found that 
other quality meat traits can also be enhanced with the 
method of the invention. 
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METHODS AND COMPOSITIONS TO ENHANCE 
TENDERNESS AND VALUE OF MEAT 
0001. This application is related to U. S. Provisional 
Application, Ser. No. 60/204,210, filed May 12, 2000, which 
is incorporated herein by reference. 
BACKGROUND OF INVENTION 
0002 The present invention relates generally to enhance 
ment of desirable attributes of meat; compositions and 
methods for accomplishing Such enhancement; and to the 
meat enhanced by Such compositions and methods. More 
particularly, the present invention relates to the treatment of 
whole pre-rigor Skeletal muscle, either while on the carcass 
or after excision, employing compositions of the invention 
which are applied to pre-rigor muscle to obtain a significant 
enhancement in tenderneSS and other desirable attributes of 
meat. 
0003. The publications and other materials used herein to 
illuminate the background of the invention, and in particular 
cases, to provide additional details respecting the practice, 
are incorporated by reference, and for convenience are 
referenced in the following text by author and date and are 
listed alphabetically by author in the attachments hereto. 
0004 Tenderness is reported to be the trait most affecting 
consumer acceptance of beef, while lean color is reportedly 
the most important attribute at point of purchase (Faustman 
and Cassens, 1991). Tenderness of meat is the sum total of 
the mechanical Strength of skeletal muscle tissue and its 
weakening during postmortem aging of meat (Takahashi, 
1996). Kamstra and Saffle (1959) described tenderness as an 
elusive characteristic because many of the factors which 
contribute to it are in a continual State of change from the 
time of animal Slaughter. Much research during the past 50 
years has been devoted to study of the numerous factors that 
have been implicated in tenderneSS, Such as age, breed, Sex, 
fatness, pre-Slaughter treatments, dressing, cooling, Storage 
and cooking procedures. The relationship between normal 
early-postmortem changes and tenderneSS have been inves 
tigated. The rate at which these changes occur influences 
important meat quality traits Such as tenderness, color and 
water-holding capacity (Hamm, 1982). 
0005. The U.S. beef and pork industries have funded 
research to improve the quality, consistency and uniformity 
of beef. Much of this research has been directed to improve 
ment through treatment of meat after it has gone through 
rigor mortis (post-rigor). There is an important difference 
between pre-rigor treatment and post-rigor treatment of 
meat. Several post-rigor treatments have been promoted as 
a way to enhance tenderneSS. The best known of these has 
been calcium chloride. This compound is reported to 
enhance the activity of proteolytic enzymes within meat that 
naturally improve meat tenderneSS upon extended cold Stor 
age (aging). 
0006 Previous work with sodium chloride was under 
taken to reduce the Sodium content of Sausage-type (ground/ 
processed) meat products. (Bernthal et al., 1989) The effects 
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of Sodium chloride on processing characteristics of the meat 
in Sausage formulations has also been evaluated. However, 
the possible effect of sodium chloride on tenderness of 
whole and unground muscle has not been reported. Simi 
larly, the use of glucose has been evaluated as a way to 
reduce the amount of Sodium added to Sausage ingredients. 
(Young et al., 1988) Dalrymple and Hamm (1974) showed 
that Salt addition to pre-rigor muscle minces reduced phos 
phorylase activity. Phosphates have been used at levels of 
1-2% to increase the amount of water bound by muscle, i.e., 
to improve water holding capacity, by increasing meat pH 
and solubilizing proteins (Bernthal et al., 1991). Alvarez 
(1996) and Martin-Herrera (1998) reported the use of 
sodium fluoride and calcium fluoride (200 mM) to inhibit 
enolase and improve tenderneSS by increasing pH in pre 
rigor beef muscles. 
0007 Of the above attempts to alter attributes of pre-rigor 
muscle, each has disadvantages. For example, both Salt and 
phosphate impart distinct flavor profiles and frequently alter 
color. Salt is also a pro-oxidant and its use increases oxida 
tive rancidity and reduces color stability of meat. Use of 
phosphate is limited by law to 0.5% and, furthermore, it 
generates Soapy flavors at high levels. Sodium acetate and 
Sodium citrate have been added to meat to enhance shelf life. 
Citric acid sprays have been used as a Surface Spray for 
animal carcasses to inhibit microbial growth. Acid marina 
tion causes Significant flavor changes and can alter the 
texture of the meat and make it mushy. Sodium fluoride has 
been reported to enhance tenderneSS and maintain fresh meat 
color, however, sodium fluoride is not approved in the U.S. 
for addition to meat products. 
0008 Most beef is cut into steaks and roasts, or ground 
for ground beef, after it has undergone a chilling process 
following harvest. This allows the normal rigor mortis 
(rigor) process to occur within muscle. One consequence of 
rigor development is production of lactic acid within the 
meat, resulting in a pH lower than pre-rigor muscle. 
Although the pH of different post-mortem muscle types can 
be quite different, meat of a given type which has a relatively 
higher pH is generally associated with an increased tender 
ization (Harrell et al., 1978; Watanabe et al., 1996; Beltranet 
al., 1997). The increased tenderness at high pH has been 
attributed by some to the direct effect of pH on the activity 
of the proteolytic enzymes which degrade the myofibrillar 
structure of the muscle (Yu and Lee, 1986). However, the 
results of investigations of the effect of pH on tenderneSS 
have been inconsistent. For example, Wulf et al. (1997), 
reports that higher pH (dark-cutting) beef is less tender. 
0009. Although there are reports of the beneficial effect 
of pH on tenderneSS of meat, high pH meat is quite dark in 
color and SufferS Severe loSS in value as a consequence. 
However, as with studies of the correlation of pH and 
tenderness, the reported association of color with tenderneSS 
is inconsistent. Wulf et al. (1997) reported that dark-cutting 
beef is less tender. Conversely, Jeremiah et al. (1991) 
reported that beef carcass with dark color produced more 
tender Steaks. Strategies to increase pH while preserving 
desirable color would be of importance to the industry. 
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0.010 Changes in another attribute of muscle, sarcomere 
length (SL), have been reported to be related to tenderness. 
Longer Sarcomeres have been associated with greater ten 
derness (Hostetler et al., 1972; Bouton et al., 1973; Davis et 
al., 1979; Koohmaraie et al., 1996). Muscles shorten when 
they enter the rigor State. Temperature and pH also have 
been reported to play an important role in Sarcomere length. 
Hertzman et al. (1993) showed that the rate of shortening 
increases with increasing temperature from 10° C. to 37 C. 
However, temperatures below 10° C. in more severe short 
ening (Honikel et al., 1981). Locker and Hagyard (1963) 
reported minimum shortening between 15 and 20° C. for 
Sternomandibularis beef muscles. 
0.011 Among muscle types, there are significant differ 
ences in the pattern of postmortem glycolysis and the onset 
of rigor (Ouali and Talmant, 1990). Meat quality attributes, 
including color, texture and tenderness, are also related to 
fiber characteristics of the muscle (Cassens and Cooper, 
1971). 
0012. A method which enhances tenderness while main 
taining desirable color of a wide Spectrum of muscle types 
would upgrade the value, especially of lower-value cuts, and 
enhance customer Satisfaction. It is desired to develop a 
treatment for beef which enhances tenderness of diverse 
muscle types, without over-tenderization. It is also desired to 
find a treatment to enhance tenderneSS which will not 
negatively impact meat color or flavor. 
SUMMARY OF INVENTION 
0013 The present invention relates generally to enhance 
ment of desirable attributes of meat; compositions and 
methods for accomplishing Such enhancement; and to the 
meat enhanced by Such compositions and methods. More 
particularly, the present invention relates to the treatment of 
pre-rigor muscle, either while on the carcass or after exci 
Sion, employing compositions of the invention which are 
applied to pre-rigor muscle to obtain a significant enhance 
ment in tenderneSS and other desirable attributes of meat. 
BRIEF DESCRIPTION OF THE FIGURES IN 
ATTACHMENTS 
0.014 FIG. 1 shows the effects of marination on pH and 
Shear force in pre-rigor longissimus lumborum muscle. 
0015 FIG. 2 shows the effects of marination on pH and 
Shear force in pre-rigor rectus abdominis muscle. 
0016 FIG. 3 shows the effects of marination on pH and 
Shear force in pre-rigor cutaneous trunci muscle. 
0017 FIG. 4 shows effects of marination on visual color 
in pre-rigor longissimus lumborum muscle. 
0018 FIG. 5 shows effects of marination on visual color 
in pre-rigor rectus abdominous muscle. 
0019 FIG. 6 shows effects of marination on visual color 
in pre-rigor cutaneous trunci muscle. 
DETAILED DESCRIPTION OF THE 
INVENTION 
0020. The present invention relates generally to enhance 
ment of desirable attributes of meat; compositions and 
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methods for accomplishing Such enhancement; and to the 
meat enhanced by Such compositions and methods. More 
particularly, the present invention relates to the treatment of 
whole pre-rigor Skeletal muscle, either while on the carcass 
or after excision, employing compositions of the invention 
which are applied to pre-rigor muscle to obtain a significant 
enhancement in tenderneSS and other desirable attributes of 
meat. 
0021. In accordance with the method of the present 
invention a composition is applied to pre-rigor Skeletal 
muscle after harvesting and evisceration. The pre-rigor 
muscle may be manually or mechanically removed from the 
skeleton before application of the compositions of the 
instant invention. Alternatively, the entire carcass, or a 
portion thereof, could be used with the skeletal muscle fully 
or partially attached to the skeleton. 
0022. In one embodiment of the present invention, the 
method Serves to enhance one or more quality meat traits. In 
a first aspect of this embodiment, the enhanced attribute is 
tenderneSS. In a Second aspect of this embodiment, the 
attribute is reduced detriment in lean color. In a third aspect 
of this embodiment, the attribute is absence of off flavors. In 
a fourth aspect, the attributes include a combination of two 
or more of the above attributes. 
0023. In another embodiment of the invention, the means 
of application of the compositions of the present invention 
to pre-rigor muscle can be carried out by any of those means 
known in the art. In a first aspect of this embodiment, the 
compositions of the invention may be applied by direct 
injection into the muscle (pumping) when the muscle is on 
the carcass. In a Second aspect of this embodiment, the 
compounds of the invention may be applied by direct 
injection after the muscle has been excised from the carcass. 
Injection may be accomplished by manual or mechanical 
means. In a third aspect of this embodiment, the composi 
tions of the invention may be applied by marination of the 
muscle. In a fourth aspect, the compositions may be applied 
by injection into vein or artery, including infusion of the 
animal body. In a fifth aspect, application of the composi 
tions of the invention may be augmented by high-pressure 
Spray or vacuum System for delivering the compositions to 
the muscle. In a sixth aspect of this embodiment, the 
compositions of the invention may be applied by a combi 
nation of two or more of the above methods. Further details 
of suitable methods of application are set forth in the 
Examples. 
0024 Compositions useful in the practice of the inven 
tion include Solutions of citric acid and its Salts, glucose, 
Sodium oxalate, oxamic acid, Sodium acetate, and combina 
tions thereof. It is preferred to use citric acid and/or one of 
its Salts, most preferably Sodium citrate. From a biochemical 
perspective, it is primarily though not exclusively the citrate 
portion of the molecule that directly or indirectly produces 
the enhancement in quality meat trait. The concentrations of 
the compositions useful in the practice of the invention can 
be determined in part by the degree of enhancement desired, 
and otherwise as dependent upon the method of application 
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of the compositions of the invention to the muscle and the 
further processing Strategies and products desired, as 
described elsewhere herein. The range concentrations of 
Solutions, including the compositions of the invention is 
between about 0.1% to about 10% when the compositions 
are to be applied by injection of muscle and preferably 0.5% 
to 8%, most preferably 0.5% to 5%. When the compositions 
of the invention are applied by marination, it can be desir 
able to hasten uptake and therefore the range would in Some 
cases be higher, between 0.1% and about 20%, preferably 
0.5% to 15%. When the application is by infusion, the range 
would be between about 0.1% and about 15%. 
0025. The present invention will be described with ref 
erence to a variety of beef muscle types as the Source of 
skeletal muscle. However, it is understood that this descrip 
tion is merely illustrative and the invention is applicable to 
muscle of any animal which is produced for human or 
animal consumption and to skeletal muscles of any mixture 
of muscle fiber types. From a manufacturing perspective, 
different muscle types and skeletal muscle of different 
Species behave in a similar manner. For example, Virtually 
all of the meat processing equipment in the industry works 
on meat from any species (with the possible exception of 
fish). The grinders, mixers, Stuffers, and tumblers used in a 
poultry meat operation are often identical to equipment used 
for beef or pork. Thus, it is appropriate to extrapolate these 
results to all striated, Skeletal muscle. Biochemistry of 
muscle is consistent acroSS Species to Such an extent that the 
focus is on the few subtle differences rather than the simi 
larities among muscle types. The post-mortem biochemistry 
of all striated, Skeletal muscle is similar. They rely on 
glycolysis (the degradation of endogenous glycogen) to 
generate energy (ATP) within the muscle during rigor, 
thereby producing lactic acid and dropping muscle pH. The 
Same biological Structures exist-at both the cellular as well 
as the tissue level. Given the common biochemistry of 
striated Skeletal muscles, Similar results are to be expected 
with Skeletal muscle, including, but not limited to, muscle of 
pork, lamb, poultry, deer, bison and llama. In a first aspect 
of this embodiment, the compounds may be used to enhance 
attributes of beef. In a second aspect of this embodiment, the 
compounds may be used to enhance attributes of pork. In a 
third aspect of this embodiment, the compounds may be 
used to enhance attributes of lamb. In a fourth aspect of this 
embodiment, the compounds may be used to enhance 
attributes of poultry. In a fifth aspect of this embodiment, the 
compounds may be used to enhance attributes of llama. In 
a sixth aspect of this embodiment, the compounds may be 
used to enhance attributes of deer. In a Seventh aspect of this 
embodiment, the compounds enhance bison. 
0026. It is anticipated that the meat produced by the 
method of the instant invention can be used in a wide variety 
of meat products including, without limitation, meat prod 
ucts that are vacuum packaged, frozen and flaked, pre 
cooked and Steaks. 
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0027 Definitions 
0028. The present invention employs the following defi 
nitions: 
0029) “Aging of muscle” refers to refers to the storage of 
meat or muscle foods at refrigerator temperatures. 
0030) “Enhanced tenderness” refers to the reduced shear 
force and/or increased desirability of taste panel tenderneSS 
ratings which occurs as a result of treatment. 
0031) “High pH” when referring to the ultimate pH value 
of muscle or meat means a pH (acidity) reading that is higher 
than that normally found in muscle or meat after the comple 
tion of rigor mortis. 
0032) “Hot boned” and “hot boning” refers to removal of 
meat from carcasses prior to rigor mortis. 
0033 “Lean color” refers to the ultimate color of meat 
after exposure to air and binding of oxygen to myoglobin 
which impart a bright, cherry red color to the meat. Lean 
color may be described in terms of redness, brightness, hue, 
and many other objective and Subjective terms. 
0034). “Meat” shall include, without limitation, both 
cooked and uncooked meats irrespective of the State of 
rigor-mortis, and all edible meats, Such as, for example, 
beef, pork, lamb, deer, bison, poultry and the like. 
0035 “Meat quality traits” refer to those characteristics 
of meat or muscle foods that influence the appearance, 
eating quality or processing quality of the meat or are 
indicative of Such characteristics. Examples include color, 
tenderness, flavor, juicineSS, and water holding capacity, 
among others. 
0036 “Meat texture” refers to the physical properties of 
meat and muscle relating to eating quality, including ten 
derneSS. 
0037 “Microbial stability” refers to the ability of the 
meat or muscle product to maintain micro-organisms at their 
current level and resist (or slow) excessive growth of 
Spoilage micro-organisms. 
0038 “Muscle type” refers to the broad classification of 
striated, skeletal muscle into categories based upon their 
blend of muscle fiber type. Muscles are comprised of a mix 
of muscle fiber types. Each fiber (muscle cell) can be 
classified by Several different Systems as a particular type. 
One example of a classification System is red, intermediate, 
and white. Another is beta-red, alpha-red, and alpha white. 
Still others classify as type I, type IIA, and type IIB. Each 
System depends on Specific biochemical and biophysical 
characteristics of the muscle. Skeletal muscles are com 
prised of a blend of muscle fiber types. Thus, whole skeletal 
muscles are often classified on the basis of the predominate 
nature of their fiber type profile. Those with many beta-red 
fibers might be considered “red” muscles while those with 
many alpha-white muscle fibers would be considered 
“white” muscles. This is an imperfect System because even 
the “white' muscles contain Some beta-red fibers. Skeletal 
muscles exhibit characteristics that can be associated with 
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one or more muscle fiber types, depending on the relative 
proportions of different muscle fiber types. 
0039) “Off-flavor” refers to a flavor not usually associ 
ated with fresh meat. 
0040 “Oxidation reduction potential” refers to the bio 
chemical ability of the muscle/meat to counter oxidation 
through Subsequent reduction of the oxidized compounds. 
0041) “Pre-rigor” refers to muscle that has not completed 
the process of rigor mortis or attained its ultimate, post 
Slaughter pH. 
0042 “Sarcomere length” or "SL" reflects the degree of 
muscle contraction present in the muscle. 
0.043 “Shear force” refers to the amount of mechanical 
force needed to cut a core of meat; a Standardized procedure 
to provide an objective measure of meat tenderneSS. 
0044) “Sodium citrate” is used herein to refer to citric 
acid and its Salts, and includes Sodium citrate, calcium 
citrate and other salts of citric acid. The USDA considers 
citric acid and its Salts to be covered by the phrase, citric 
acid. (9 CFR $318.7) 
0.045 “Tenderness of meat” refers to objective measures 
and/or Subjective measure of the amount of force needed to 
cut or fragment cooked meat. 
0046) “Whole pre-rigorskeletal muscle” refers to striated 
skeletal muscle from animals used for meat. 
0047 The various embodiments of the present invention 
described herein are based on the discovery of compounds 
which enhance meat quality traits of all types of pre-rigor 
skeletal muscle. For example, Sodium citrate was identified 
to enhance tenderness of muscle when used as a pre-rigor 
treatment. Similar effects were found with other compounds 
Such as glucose, Sodium oxalate, oxamic acid and Sodium 
acetate. It has been discovered that pre-rigor muscles treated 
with these compounds were Superior in tenderneSS to 
untreated muscle, despite a Severe muscle shortening in 
excised muscle as evidenced by reduced Sarcomere length. 
Particularly Surprising was the magnitude of enhancement of 
tenderneSS with the compounds of the invention and that 
treated muscle color was affected to a lesser degree than it 
is in muscle where ultimate pH occurs naturally or after 
addition of other ingredients. Additional advantages with the 
use of the compounds of the invention are more desirable 
taste panel Scores for juicineSS, amount of connective tissue 
and flavor. Furthermore, Sodium citrate is approved as a 
chemical preservative for addition to whole muscle prod 
ucts, cured products and as a Surface application. (9 CFR 
$318.7(c)(4), Ch. 111 (1-1-100 Edition), U.S. Dept. Ag. 
(1998)). 
0048 Preliminary Trials 
0049. In several preliminary trials, pre-rigor beef muscle 
was tested for Several quality meat traits after treatment by 
one of three procedures. 
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0050 Homogenized Muscle 
0051 Pre-rigor beef muscle was homogenized 100 mL of 
treatment solution, held at 2 C. for up to 24 hours before 
testing pH and oxidation-reduction potential of the homo 
genate. The treatment Solutions were as follows: Sodium 
chloride (330 mM), sodium citrate (100 mM), sodium 
acetate (100 mM), iodoacetate (50 mM), oxamic acid (50 
mM), glucose (330 mM), sodium diphosphate (100 mM), 
sodium fluoride (100 mM), sodium oxalate (50 mM), cal 
cium iodate (50 mM), calcium chloride (300 mM), and 
water (control). All treatments except calcium chloride pro 
duced higher pH than the control. Two of the compounds are 
approved food ingredients; however, iodoacetate, oxamic 
acid, Sodium oxalate and calcium iodate have toxic speci 
fications and regulatory limits. 
0.052 Sectioned Muscle 
0053 Pre-rigor beef muscle was sectioned into 100 g. 
Samples at approximately 3 hours post-mortem. The pieces 
were injected with 10 mL of treatment solution followed by 
marination in the solution for 24 hours at 2 C. before testing 
pH and recording Visual color of the muscle Sections. For 
evaluation of shear force, Samples were thawed, cooked, 
Sliced (approximately 6 mm by 6 mm) and then cooled 
before readings were taken. The Solutions used for this 
procedure were as described above for homogenized 
muscle. 
0054 Contrary to results suggested with the homog 
enized muscle trials, not all treatments resulted in higher pH 
than the control. Furthermore, results from different muscle 
types varied widely as to Shear force values as compared to 
the control. However, the sectioned muscle itself was very 
thin with high connective tissue content, which made it 
difficult to obtain accurate results for shear force. Most of the 
treatment Solutions used in these procedures caused different 
responses among muscle types. 
0055 (FIGS. 1-6) 
0056 Sectioned Muscle 
0057 Pre-rigor beef muscle was sectioned and the sec 
tions were injected at approximately 1 hour post-mortem 
with a volume of treatment solution equal to 10% of the 
muscle weight. Objective color measurements were taken on 
pieces of each muscle Section and the pieces were then 
frozen, powdered and stored at -80 C. for up to 10 days 
before testing pH and analyzing oxidation-reduction poten 
tial. Shear force was evaluated as described immediately 
above. Solutions used in this procedure were as follows: 
sodium citrate (200 mM), sodium acetate (200 mM), glucose 
(300 mM), calcium citrate (200 mM), calcium chloride (300 
mM), injection with water, and no injection (control). The 
calcium citrate Solution was prepared as a Suspension using 
0.25% carrageenan and 200 mM calcium citrate due to its 
insolubility in water. However, use of calcium citrate can be 
optimized by increasing Solubility by means known in the 
art. Results are shown in Tables 1 and 2. 
0058 Muscle samples used in the preliminary trials 
underwent considerable physical manipulation prior to 
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application of treatments and assessment of results. Excised 
muscles were either homogenized in a blender or cut pre 
rigor into Subsamples for application of the various treat 
ments. This much manipulation would be expected to accel 
erate post-mortem metabolism. As a result, it was not 
possible to reliably predict the effect of treatment with the 
compositions of the invention on whole skeletal muscle 
when it was treated, pre-rigor, before homogenizing or 
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0062) 4) No changes in lightness (L*) of whole 
muscle were anticipated contrary to treatment of 
Sectioned muscles. 
0063. It has been discovered that, with the method of the 
present invention wherein pre-rigor whole muscle is treated, 
citric acid and its Salts, glucose, Sodium oxalate, oxamic acid 
and Sodium acetate reduce the pH decline normally 
observed; rather than having the pH drop to approximately 
5.6, the ultimate (post-rigor) muscle pH is higher. 
TABLE 1. 
Effect of pre-rigor injection on pH, oxidation-reduction potential and shear force 
of sternomandibularis beef muscles. 
Variable 
Redox Shear 
PH pH Redox potential, potential, mV force, kg 
Treatment (O h) (72 h) mV (Oh) (72 h) (72 h) 
Calcium chloride 6.77 5.88d 131.OO 139.95 6.61 
Glucose 6.81 5.82cd 128.91 14131 13.7Ob 
Sodium citrate 6.86 5.77bc 135.45 152.40 11.09ab 
Sodium acetate 6.86 5.8Ocd 128.98 131.88 9.88ab 
Calcium citrate 6.92 5.82cd 128.70 126.60 7.57a 
Control Water 6.95 5.66ab 127.51 141.76 14.44 
Control no-water 6.84 5.65a 135.60 145.30 14.03 
SD .04 O3 4.04 4.21 1.44 
a,b,c,d 
Sectioning. Given the significant disruptions in the processes 
which muscle would normally undergo, which were caused 
by the homogenization and removal pre-rigor of Small 
Samples for treatment and testing in the preliminary trials, it 
was not possible to predict how treatment of whole skeletal 
muscle (as compared to homogenized or Sectioned) with the 
Several compounds, would affect tenderneSS or other meat 
quality traits. Furthermore, the preliminary trials indicated 
that different muscle types responded differently to treat 
ment and that use of different compounds would therefore be 
required. Specifically, the following differences from Screen 
ing of compounds using Sectioned or homogenized muscle 
pieces, which were among those observed when the method 
of the present invention was used to treat whole pre-rigor 
muscle: 
0059) 1) Treatment of whole muscle with sodium 
citrate produced much lower shear force values than 
treatment of Sectioned Samples of flank muscle. 
0060 2) All whole muscle types treated with sodium 
citrate responded Similarly while Sectioned muscle 
Samples responded inconsistently. 
0061 3) Surprisingly, no significant differences in 
oxidation/reduction (redox) potential were detected 
among types of treated whole muscle. Based on 
results of the preliminary trials of Sectioned muscle 
Samples, differences in redox potential among 
muscle types was anticipated. 
means bearing the same letters within a column are not significantly different at P < 
0.064 
TABLE 2 
Effect of pre-rigor injection on color of sternomandibularis 
beef muscles. 
Variable 
L*value a value b value L* value a value 
Treatment (O h) (O h) (O h) (72 h) (72 h) 
Calcium 27.53 17.03 3.16 27.75 22.90 
chloride 
Glucose 27.86 19.26 4.29 27.57 27.53 
Sodium citrate 24.27 23.82 5.16 30.83 25.10 
Sodium acetate 23.60 20.17 4.69 28.64 21.26 
Calcium citrate 27.37 20.41 3.89 29.05 25.27 
Control Water 28.07 19.03 3.82 28.05 24.65 
Control 26.45 17.08 2.57 27.01 22.51 
no-Water 
SD 1.69 2.22 72 2.18 1.12 
Comparison within a column are not significantly different (P< .05). 
*L* = lightness; 100 = white, 0 = black. 
a* = redness; -80 = green, 100 = red. 
*b* = yellowness: -50 = blue, 70 = yellow. 
EXAMPLES 
0065. The following examples are illustrative of the 
present invention and are not intended to limit the Scope of 
the invention. Standard techniques well-known in the art or 
the techniques specifically described below are utilized. 
Example 1 
Pre-rigor Injection of Whole Muscle 
0066 Experiment were conducted to test the effects of 
pre-rigor injection of Several compounds. Effects of these 
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compounds on pH, color, tenderneSS and other related traits 
of low-value beef cuts were investigated. Ten steers (22 to 
24 mo of age, 515 to 676 kg live weight) were slaughtered 
according to current industry procedures. Pre-rigor Semi 
membranosus (from the round), triceps brachii and 
Supraspinatus muscles (from the chuck) were excised, after 
evisceration (approximately 1 hour post-mortem), from both 
Sides of the carcass. Muscle Sections were randomly 
assigned to the treatments: sodium citrate (NaC; 200 mM), 
sodium fluoride (NaF; 200 mM), sodium acetate (NaA; 200 
mM), and calcium chloride (CaCl, 300 mM). The control 
Samples remained on the carcass at 2 C. for 24 hours to 
Simulate commercial conditions. Following a cooling, con 
trol muscles were removed from each carcass (4 replicates), 
Vacuum packaged and transferred to the holding cooler with 
the other cuts at 2 C. Calcium chloride treatment was 
included to be compared with the other treatments. 
0067. At 2 hours post-mortem, each muscle was injected 
with a volume equal to 8% of the muscle weight using a 
four-needle hand injector. The temperature of Solutions were 
4° C. Each muscle was individually treated (2% of solution 
was added to give a total of 10% of muscle weight) and 
tumbled in a 75-pound capacity tumbler (Röschermatic, 
Oshabrick, Germany) for 30 min to insure uniform distri 
bution of the Solution. 
0068 Samples of each muscle (approximately 100 g) 
were taken at 0 hour (before injection), 24, and 72 hours 
after injection for determination of pH, oxidation-reduction 
potential, glycogen content, R-values, NAD, and NADH. 
The Samples were then immediately frozen in liquid nitro 
gen and stored at -80 C. until they were powdered and 
analyzed. Fresh muscle samples (approximately 20 g) were 
taken at 72 hours after injection and assayed immediately for 
water holding capacity and Sarcomere length. Evaluation of 
all traits before injection (0 hour), indicated that initial 
characteristics of all meat types were Similar at the begin 
ning of the experiment. 
0069 Sodium citrate (NaC) treatments enhanced muscle 
tenderneSS in whole pre-rigor muscle of all muscle types, 
without detriment to lean color and maintained a pH which 
was higher than the control. (Tables 3, 7, and 11) Injection 
of NaC in Triceps brachii produced the most tender meat 
(P<0.05) at 3 days. Tenderness also improved with CaCl 
during aging; however, differences were of lesser magnitude 
(P<0.05) after 7 days and not significant by day 14. The 
Same trend was observed in SemimembranoSuS with no 
significant differences. Injection of NaC, CaCl, and NaFin 
Supraspinatus significantly reduced shear force by 2.22 kg, 
1.73 kg, and 1.15 kg (Table 8), respectively compared with 
controls at 3 days post-mortem, with no significant differ 
ences with these treatments at 7 days post-mortem. How 
ever, there was a significant increase in Shear force with NaA 
treatment at 7 days post-mortem. Water holding capacity and 
L* value were not significantly affected by type of treatment. 
However, treated samples showed lower a values than the 
controls of all muscles. Treatment did not affect oxidation 
reduction potential, but all muscles became more oxidative 
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(higher oxidation-reduction potential) after 3 days. Treated 
muscles had higher NAD and NADH content than controls 
(P<0.05); however this change did not affect lean color. 
0070 Triceps Brachii Muscle 
0071 All treated muscles had higher pH values and 
glycogen content than control (P<0.05) at 24 and 72 hours 
post-mortem, with those containing NaF and NaC having 
the highest values at both sampling periods (Table 3). These 
results provide clear evidence that postmortem glycolysis 
was in fact inhibited. R-value is the ratio of hypoxanthine to 
nucleotide concentrations, which indicates the State of rigor 
mortis (Honikel and Fischer, 1977). It was not possible to 
determine if muscle Sections with any treatment entered 
rigor in advance of the control because no differences were 
detected in R-Values at any Sampling periods, indicating that 
after 24 hours, all muscles were in Similar Stages of rigor. No 
differences in water holding capacity (WHC) were observed 
despite differing pH values, perhaps because treated muscles 
contained 10% added liquid. Sarcomeres were shorter with 
all treatments than with the control (Table 4). Despite 
muscle shortening, triceps brachii muscles treated with NaC 
were (P<0.05) more tender after 3 days postmortem than the 
control (Table 4). Improvement in tenderness was also 
observed in samples treated with NaF or CaCl Treatment 
with NaF and CaCl affected shear force value; however, the 
affects were of lesser magnitude (P<0.05) after 7 days of 
aging than after 3 days and not significant by day 14. It is 
notable that treatment with NaC resulted in lower shear 
force values than CaCl at day 7. Samples treated with NaA 
did not improve in tenderneSS and the pH was significantly 
lower at 24 and 72 hours than Samples containing NaC or 
NAF. 
0072. It is desired to maintain an elevated pH without 
compromising color. Treatments did not affect L* and b* 
values (P>0.05). There were slightly, but significantly 
(P<0.05), lower a values for treated muscles (Table 5) 
compared to the control at 72 hours. This may Suggest a 
dilution effect due to the addition of 10% of muscle weight 
as the treatment Solution. Reducing conditions (redox poten 
tial), NAD and NADH content were characterized among 
treatments because they are likely to affect color. Glycolytic 
inhibitors (NaA, NaC and NaF) resulted in the highest NAD 
concentration at 24 and 72 hours post-mortem (P<0.05), but 
these differences were not of Sufficient magnitude to be 
reflected in redox potential. All samples showed the trend of 
decreasing reducing capacity (higher mV values) over time 
(Table 6). No differences were found in NADH content 
during treatments. 
0073 Supraspinatus Muscles 
0074 Samples treated with NaF or NaC had higher pH 
(P<0.05) than the control at 24 hours(>6.0) and 72 
hours(>5.8). Those two treatments also had higher glycogen 
content (P<0.05 only at 72 hours). These results provide 
evidence that glycolysis was inhibited. As expected, WHC 
increased in muscles with higher pH, but these differences 
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were not significant (Table 7). Similar to results found in 
triceps brachii, no differences were detected in R-Values at 
any Sampling periods. 
0075 Sarcomere lengths of treated muscles were shorter 
than that of the controls (P<0.05) at 72 hours. However, 
injection of NaC, CaCl, or NaF in pre-rigor Supraspinatus 
reduced shear force values by 2.22 kg, 1.73 kg, and 1.15 kg, 
respectively, compared with the controls at day 3 (Table 8). 
TenderneSS improved over time, however, no differences 
were detected (P>0.05) between treated samples and the 
controls after 7 days aging. 
0076 Muscles injected with NaF had the lowest a* 
values (less red) and b* values (less yellow) than control 
(Table 9) at 24 and 72 hours. Although not significant, NaC 
and NaA treated Samples were also leSS red and yellow than 
the controls. Treatments affected neither reducing potential 
nor NADH content, however a slight, but significant, dif 
ference in NAD was detected in treated samples. Treated 
samples had higher NAD content than the controls. 
0077 Semimembranosus Muscles 
0078 Muscles treated with NaFor NaC had elevated pH 
values and greater glycogen content than the controls at 24 
and 72 days postmortem. R-values indicated that muscles 
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injected with NaF entered rigor more rapidly (showed a 
significant high R-value at 24 hours, Table 12) than the 
controls, indicating NaF arrested glycolysis for at least 3 
days. 
0079 All treated samples had shorter sarcomere length 
than the control at 72 hours post-mortem (Table 12). The 
Shortest Sarcomere length was observed in Samples injected 
with CaCl (1.48 um) and NaF (1.53 um). The same ten 
derizing effects of NaF and NaC found in Supraspinatus and 
Triceps brachii samples were observed in semimembrano 
SuS Samples. Significant differences between treatments 
were not detected (P>0.05). 
0080. Different treatments did not significantly affect L* 
values, but treated Samples were less red (lower a values) 
and less yellow (lower b values) than controls at 72 hours 
post-mortem. All treated Samples showed a decreasing 
reducing capacity (higher mV values) over time (P<0.05). 
Treated Samples also had significantly higher NAD and 
NADH content than the controls at 24 and 72 hours post 
mortem. It was noticed that NaA produced the lowest 
reducing capacity and the highest NAD and NADH content 
(P<0.05). 
TABLE 3 
Effect of pre-rigor injection on pH, water holding capacity and glycogen content of 
triceps brachi beef muscles. 
Variable 
pH, Oh 
pH, 24 h. 
pH, 72 h 
WHC, 72 h, 
Glycogen, Oh 
Glycogen, 24h 
Glycogen, 72 h 19.66 
Treatment 
Calcium Sodium Sodium Sodium 
Control chloride acetate" fluoride" Citrate" SE 
6.77 6.78 6.76 6.71 O3 
5.61 5.84b 5.8Ob 6.07a 5.97a O5 
5.28d 5.67 5.48 5.95a 5.72b .04 
33.66 40.09 36.36 35.27 37.76 1.10 
39.14 49.53 48.22 38.74 3.62 
30.88 28.76b 28.74b 43.98 32.93 2.78 
25.01 be 27.22b 37.30a 27.58 2.26 
means bearing the same letters within a row are not significantly different at P < .05. 
"muscles remained in the carcass at 2 C. for 24 h. 
concentration: 300 mM; "concentration: 200 mM. 




Effect of pre-rigor injection on R-value, sarcomere length and shear force of 
triceps brachi beef muscles. 
Variable 
R-values, Oh 
R-value, 24 h. 
R-values, 72 h 
Treatment 
Calcium Sodium Sodium Sodium 
Control chloride acetate fluoride citrate SE 
81 8O 86 85 O3 
1.27 1.31 1.31 1.28 1.30 O2 
1.38 1.44 140 1.38 1.36 O2 
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TABLE 4-continued 
Effect of pre-rigor injection on R-value, sarcomere length and shear force of 
triceps brachi beef muscles. 
Treatment 
Calcium Sodium Sodium Sodium 
Variable Control chloride acetate fluoride citrate SE 
Sarcomere length (um) 2.41 131 153 141 1.62 .11 
Shear force (kg), 3 d 5.75 ab 4.95be 6.47a 5.18be 4.54 .30 
Shear force (kg), 7 d 4.16 487b 5.96a 4.82 4.20 18 
Shear force (kg), 14 d 4.01 4.07 4.67 4.09 3.69 27 
means bearing the same letters within a row are not significantly different at P < .05. 
'see table 1, for treatments description. 
R-value is the ratio of hypoxantine to nucleotide concentration (an indicator of rigor 
mortis). 
0082) 0084) 
TABLE 5 TABLE 7 
Effect of pre-rigor iniection on color of triceps brachii muscles. Effect of pre-rigor injection on pH, water holding 
f capacity and glycogen content of Supraspinatus beef muscles. Treatment 
f 
Calcium Sodium Sodium Sodium Treatment 
Variable Control chloride acetate fluoride Citrate SE 
Calcium Sodium Sodium Sodium 
L*values, Oh 21.61 17.72 20.76 22.22 1.22 Variable Control chloride acetate fluoride Citrate SE 
L*values 24 h. 28.94 28.34 28.37 29.58 28.52 1.01 
Eas th 28.19 3. 2. 5. I pH, Oh - 6.75 6.81 6.72 6.73 .04 
a value, d C C al 
a value", 24 h. 24.64 27.23 25.08 22:40 24.54 1.27 pH, 24h 5. s s 0. O2 
a value, 72 h 25.26e 23.18ab 21.87ab 23.83be 21.18a .71 pH, 72 h 5.45 5.54 5.64 6.09 5.86 O6 
bvalue, Oh 3.45 2.88 3.17 2.89 27 WHCs, 72 h 40.03 36.71 35.94 34.19 32.72 1.O1 
bvalue', 24 h. 6.56 7.10 6.55 6.05 6.56 28 Glycogen", Oh 37.98 42.83 45.49 45.18 5.49 
b*value', 72 h 6.5O 6.22 6.38 6.39 5.73 23 Glycogen", 24 h 26.37 26.75 24.43 37.37 30.43 4.39 
Gl h, 72 h 16.79b 1931 18.10 30.46a 22.65a 2.92 
'means bearing the same letters within a row are not significantly dif- ycogen, 
ferent at P & .05. 
'see table 1, for treatments description. 'means bearing the same letters within a row are not significantly dif 
SL* = lightness; 100 = white, 0 = black. ferent at P & .05. 
"a = redness; -80 = green, 100 = red. 'see table 1, for treatments description. 




Effect of pre-rigor injection on Redox potential and NAD-NADH content of 
triceps brachi beef muscles. 
Treatment 
Calcium Sodium Sodium Sodium 
Variable Control chloride acetate fluoride citrate SE 
Redox potential, Oh 12037 12110 128.27 122.63 1.56 
Redox potential, 24h 115.43 127.10 129.13 131.35 125.05 1.24 
Redox potential, 72 h 131.18 134.35 139.27 139.78 133.65 2.06 
NAD, Oh .425 .442 450 .421 O36 
NAD, 24 h O67 193b 258a 261a 269a .017 
NAD, 72 h. O52b 117a 141 113a 146 .016 
NADH, Oh O8O O87 O78 O93 OO4 
NADH, 24 h. O61 O62 O76 O60 O67 OO4 
NADH, 72 h .044 O52 O59 O55 O51 OO4 
a,b,c means bearing the same letters within a row are not significantly different at P < .05. 
'see table 1, for treatments description. 
Redox potential is expressed as mV. 
NAD and NADH are expressed as tumol/g tissue. 
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0085 
TABLE 8 
Effect of pre-rigor injection on pH, water holding capacity and glycogen 
content of Supraspinatus beef muscles. 
Treatment 
Calcium Sodium Sodium Sodium 
Variable Control chloride acetate fluoride citrate SE 
R-values, Oh 85 84 .79 84 O2 
R-values, 24h 1.28 1.26 1.30 1.28 1.27 O2 
R-values, 72 h 1.34 1.43 1.41 1.37 1.38 O2 
Sarcomere length (um) 2.13 1.30 144be 158 1.46 .11 
Shear force (kg), 3 d 7.28ab 5.55e 7.85a 6.13be 5.06 49 
Shear force (kg), 7 d 487b 4.84 6.95a 4.80 4.89 28 
a,b,c means bearing the same letters within a row are not significantly different at P < .05. 
'see table 1, for treatments description. 




Effect of pre-rigor iniection on color of Supraspinatus beef muscles. 
Effect of pre-rigor injection on color of Supraspinatus beef muscles. 
Treatment 
f 
Treatment Calcium Sodium Sodium Sodium 
Variable Control chloride acetate fluoride Citrate SE 
Calcium Sodium Sodium Sodium 
Variable Control chloride acetate fluoride Citrate SE bvalue, 24 h. 7.2Ob 6.60 6.14ab 5.32a 6.29ab 32 
b*value', 72 h 6.26 6.37 6.16 5.41 5.59 25 
L*values, Oh 20.07 20.75 22.55 21.99 1.63 
L*values, 24 h 29.61 28.41 31.37 28.71. 29.88 1.34 means bearing the same letters within a row are not significantly dif 
L*values, 72 h 28.99 30.86 33.68 28.21 30.51 1.66 ferent S. P f descripti 
* value", Oh 18.44 15.69 15.23 17.50 1.26 See ta e 1, for treatments. escription. 
a value, L* = lightness; 100 = white, 0 = black. 
a value", 24 h 27.09: 24.80 22.65a 20.78 22.83 a .89 "a = redness; -80 = green, 100 = red. 
a value, 72 h 24.19 24.27 21.67 16.66 20.87 2.36 *b* = yellowness, -50 = blue, 70 = yellow. 
b*value, Oh 3.27 2.69 2.81 3.68 31 
0087 
TABLE 10 
Effect of pre-rigor injection on Redox potential and NAD-NADH 
content of Supraspinatus beef muscles. 
Treatment 
Calcium Sodium Sodium Sodium 
Variable Control chloride acetate fluoride citrate SE 
Redox potential, Oh 122.45 121.53 124.17 124.37 2.04 
Redox potential, 24h 120.65 131.OO 130.37 131.45 11.8.17 3.98 
Redox potential, 72 h 132.2O 133.47 134.90 136.7O 125.05 3.98 
NAD, Oh 366 355 384 387 O2 
NAD, 24 h O91b 152ab 212a 216? 148a .002 
NAD, 72 h O37b O89ab 113 O78a .098 011 
NADH, Oh O74 O73 O78 O73 OO6 
NADH, 24 h. O57 O66 O64 O56 O56 OO3 
NADH, 72 h .043 O41ab O58 O45 O35 002 
means bearing the same letters within a row are not significantly different at P < .05. 
'see table 1, for treatments description. 
Redox potential is expressed as mV. 
NAD and NADH are expressed as tumol/g tissue. 
US 2002/0054941 A1 
0088) 
TABLE 11 
Effect of pre-rigor injection on pH, water holding 
gapacity and glycogen content of Semimembranosus beef muscles. 
Treatment 
Calcium Sodium Sodium Sodium 
Variable Control chloride acetate fluoride Citrate SE 
pH, Oh 6.76 6.75 6.70 6.68 O3 
pH, 24 h. 5.54c 5.77b 5.7O 6.08 5.97a 04. 
pH, 72 h 5.24 5.60 5.38d 5.97a 5.78B 04 
WHCs, 72 h 36.54 41.71 39.35 38.22 41.99 2.39 
Glycogen", Oh" - 58.18, 64.24 629O 65.12 3.59 
Glycogen", 24 h 40.80° 45.90° 40.88 54.03 52.83° 3.56 
Glycogen, 72 h 25.86° 37.10ab 28.64° 43.77a 45.65a 4.27 
'''“means bearing the same letters within a row are not significantly dif 
ferent at P &.05. 
see table 1, for treatments description. 




Effect of pre-rigor injection on R-value, 
sarcomere length and shear force of semimembranosus beef 
muscles. 
Treatment 
Calcium Sodium Sodium Sodium 
Variable Control chloride acetate fluoride Citrate SE 
R-value, Oh 83 82 85 83 O2 
R-values, 24h 1.26b 1.28b. 131ab 1.36a 1.28b O2 
R-values, 72 h 1.36 1.45 1.39 1.42 1.38 O3 
Sarcomere length 1.82 1.48° 1.74 a 1.53b 1.72 .07 
(um) 
Shear force (kg), 6.56 6.28 6.61 6.02 5.14 .46 
3 d 
Shear force (kg), 4.90 5.36 5.78 5.56 4.41 43 
7 d 
Shear force (kg), 4.06 4.03 5.08 4.60 3.96 38 
14 d 
'''“means bearing the same letters within a row are not significantly dif 
ferent at P&.05. 
see table 1, for treatments description. 
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TABLE 12-continued 
Effect of pre-rigor injection on R-value, 
sarcomere length and shear force of semimembranosus beef 
muscles. 
f Treatment 
Calcium Sodium Sodium Sodium 
Variable Control chloride acetate fluoride Citrate SE 




Effect of pre-rigor injection on color of semimembranosus beef muscles. 
Treatment 
Calcium Sodium Sodium Sodium 
Variable Control chloride acetate fluoride Citrate SE 
L* value, Oh - 20.49 18.94 20.58 20.22 1.51 
L* values, 24 h 26.78 28.61 28.47 27.70 26.87 1.48 
L* values, 72 h 29.15 29.44 32.06 27.06 30.19 1.08 
a value", Oh - 15.18 13.36 13.60 13.31. 1.15 
a value", 24 h. 26.99 b. 25.63b 24.56ab 22.54a 25.75b 92 
a value", 72 h 27.57 24.88. 20.99 22.48 21.38 1.34 
b* value, Oh 2.78 2.24 2.48 2.61 17 
b*value, 24h 7.08 6.83 6.34ab 5.89a 6.61 be 22 
b*value',72 h 7.10 6.58 5.86 5.99 5.84 39 
'''“means bearing the same letters within a row are not significantly dif 
ferent at P&.05. 
'see table , for treatments description. 
L* = lightness; 100 = white, 0 = black. 
"a = redness; -80 = green, 100 = red. 
b* = yellowness, -50 = blue, 70 = yellow. 
0091) 
TABLE 1.4 
Effect of pre-rigor injection on Redox potential and 
NAD-NADH content of semimembranosus beef muscles. 
Treatment 
Calcium Sodium Sodium Sodium 
Variable Control chloride acetate fluoride Citrate SE 
Redox potential, 120.10 122.35 125.95 12455 1.95 
Oh 
Redox potential, 118.65° 129.97 134.20a 130.07a 128.85a 2.88 
24 h. 
Redox potential, 137.12 127.92 142.75a 140.7Oab 132.67be 3.22. 
72 h. 
NAD, Oh 525 582 551 568 O27 
NAD24h 113 328ab 410 281 306 O29 
NAD,72h O72e 118be 192a .096 173ab 022 
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TABLE 14-continued 
Effect of pre-rigor injection on Redox potential and 
NAD-NADH content of semimembranosus beef muscles. 
Treatment 
Calcium Sodium Sodium Sodium 
Variable Control chloride acetate fluoride Citrate 
NADH, Oh 126 .124 130 .121 
NADH, 24 h. O7Oa O73a O90b O98b O72a 
NADH, 72 h O49a O54ab O79e O61ab .066 
'see table , for treatments description. 
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SE 
means bearing the same letters within a row are not significantly different at P3.05 
Redox potential is expressed as mV. NAD and NADH are expressed as tumol/g tissue. 
0092 Evaluation of Shear Force, pH, Oxidation-reduc 
tion Potential, Sarcomere Length, Objective Color, Water 
Holding Capacity, Glycogen Content, R-value and Dinucle 
otide Results (Example 1) 
0093. Shear Force 
0094. Tenderness of samples was evaluated by measuring 
Warner-Bratzler shear force. Steaks (2.54-cm thick) from 
the middle of each muscle were cut and frozen at 3, 7 and 
14 days postmortem. Frozen Steaks (2.54 cm thick) were 
thawed at 4 C. for 24 hours and cooked on Farberware 
Open Hearth Broilers (Model 350A Walter Kidde, Bronx, 
N.Y.) to an internal temperature of 40° C., turned, and 
cooked to a final internal temperature of 70° C. (AMSA, 
1995). Temperature was monitored using an OMEGA ther 
mocouple thermometer type T (Omega Engineering, Inc., 
Stamford, Conn.) inserted into the geometric center of a 
steak. The cooked steaks were chilled 2 hours at 2 C., and 
then 8 cores (1.27-cm diameter) were removed parallel to 
the muscle fiber orientation. Cores were sheared once each 
on an Instron Universal Testing Machine model 55R1123 
(Instron, Canton, Mass.) with a Warner-Braztler attachment. 
The Instron was set up with a 500 kg load cell, full scale 
load=1 (0-10 kg), and crosshead speed=250 mm/mim. 
0.095 Muscle pH 
0096 Duplicate pre-rigor samples (5 g) were weighed 
from powdered Sample and homogenized (Polytron, Brink 
man Instruments, New York, N.Y.) in 50 mL of 5 mM 
iodoacetic acid, 150 mM potassium chloride (pH 7.0, 24 
C.) to stop glycolysis (Ahn et al., 1992). The pH of the 
Suspension was measured with a general purpose electrode 
(Corning Glass Works, Corning, N.Y.) attached to an Orion 
Model SA 720 pH meter (Orion Research, Inc., Boston, 
Mass.). Post-rigor muscle pH was determined by homog 
enizing 5 g of sample in 50 mL of deionized water (Winger 
et al., 1979). 
0097. Oxidation-Reduction Potential 
0098. Oxidation-reduction potential in meat may be 
influenced by addition of exogenous compounds (Rodel and 
Sheuer, 1999) which may also cause color alterations in fresh 
meat. However, very limited information exists regarding 
redox potential of meat and its Significance on lean color. 
Renerre and Labas (1987) reported that muscles with the 
most unstable color showed high reducing activities. In their 
Study, redox potential in all muscles increased during Storage 
(higher oxidizing capacity). Contrary to results presented 
herein, Anh and Maurer (1989) found that under normal 
conditions, redox potential in meat decreased during post 
mortem Storage. 
0099 Duplicate, powdered samples (10 g) were weighed 
into a Waring blender cup and blended with 0.1M phosphate 
buffer (pH 6.0, 24 C.). The blender cup lid had a hole cut 
with an attached vacuum hose to minimize oxygen incor 
poration during the 15 Sec homogenization process. Samples 
were transferred to a plastic beaker and measured with a 
redox combination electrode #406080 (Corning Glass 
Works, Corning, N.Y.) attached to a pH meter (Orion Model 
SA 720 pH meter (Orion Research, Inc., Boston, Mass.). 
Reduction values of Samples were read and recorded in 
absolute mV after a 2 min equilibration. This time is enough 
to get consistent and Stable reduction potential value. Pre 
liminary experiments revealed that 2 min was a Sufficient 
amount of time to wait with the probe imbedded in the 
Sample before taking readings with the redox probe. 
0100 Sarcomere Length 
0101 Sarcomere length was determined by the neon laser 
diffraction method (Cross et al., 1981). Fresh samples were 
taken at 72 hours after injection, cut into three cubes about 
1-2 cm wide, making Sure the fibers ran longitudinally, and 
fixed in 3% glutaraldehyde solution in 0.1 M phosphate 
buffer for approximately 4 hours. Glutaraldehyde Solution 
was then replaced with 0.2 M sucrose solution. Cubes can be 
stored for up to 4 days at 2 C. in this solution. Muscle fibers 
were placed on a microScope Slide with a drop of the Sucrose 
Solution. The diffraction bands were traced on paper, moving 
the Slide around until a clear diffraction pattern was 
observed. From each cube, Sarcomere length of eight fiber 
Samples was determined (24 total measurements per obser 
Vation). Sarcomere length was calculated using the distance 
(mm) between bands and the following formula: 
0.6328 xDx V (T-- D) + 1 
Length(ium) = T 
0102 D=distance from specimen to diffraction pat 
tern screen in mm (100 mm). 
0.103 T=Spacing between diffraction bands in mm. 
0104 0.6328=wavelength of the laser 
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01.05) Objective Color 
0106 Color development, oxidation-reduction potential 
and NAD/NADH content in muscles treated with the com 
pounds of the invention were evaluated. When meat is first 
cut, the primary color pigment (myoglobin) is in a deoxy 
genated State. This gives the meat a purple tinge. When 
exposed to air, the oxygen binds to myoglobin (forming 
Oxymyoglobin), which gives a bright, cherry red color to the 
meat. When the meat is oxidized, it converts the oxymyo 
globin to metmyoglobin-the brown color of meat. The 
more reducing equivalents present in muscle, the longer the 
time before the brown color appears. 
0107 Objective color readings were taken before injec 
tion and 24 and 72 hours after injection using a Hunter Lab 
Mini Scan XE Plus Model No. 451 O-L (Hunter Associates, 
Reston, Va.), with a 2.5 cm port, Illuminant A and 20 
standard observer. It was Zeroed with the black plate and 
Standardized with a white plate. Three readings were taken 
over the entire muscle Surface and then the average was 
calculated. Readings at 24 and 72 hours post-injection were 
taken after letting muscles bloom for 30 minutes. The L*, a , 
and b values were taken as indicators of lightness, redness 
and yellowneSS, respectively. 
0108) Water Holding Capacity 
0109 Expressible moisture was measured at 72 hours 
post-mortem following a centrifugal method described by 
Jauregui et al. (1981). Three pieces of Whatman #3 filter 
paper, 5.5 cm in diameter, were folded into a thimble shape 
over the outside of an inverted 16x150 mm test tube with the 
#50 filter paper as the internal Surface thimble. The filter 
paper was weighed before and after addition of 1.5-0.3 g 
sample of muscle. The sample in the thimble was then 
centrifuged in a 50-mL centrifuge tube at 30,000xg for 15 
min at 4 C. The sample was removed and the paper was 
reweighed. Water-holding capacity was expressed as percent 
weight lost from original Sample and calculated using the 
following formula: 
final paper weight 
initial paper weight 
Expressible moisture (%) = weight of sample x 100 
0110 Glycogen Content 
0111 Glycogen extraction was performed in duplicate 
with 3 g of frozen-powdered muscle Sample, which was 
homogenized with 0.6 N perchloric acid. Amylo-O-1,4-O- 
1,6-glucosidase from Aspergillus niger (No. A3514. Sigma 
Chemical, St. Louis, Mo.) was used for the breakdown of the 
glycogen molecules to free glucose following the method 
described by Roehrig and Allred (1974). Homogenate was 
incubated for 2 hours at 37° C., then 100 uL of 3 N 
perchloric acid was added to precipitate the proteins. After 
centrifugation, the Supernatant was stored at 0-4 C., until 
analyzed, which was within 2 weeks. 
0112 The assay for glucose was run as described by 
Dalrymple and Hamm (1973) and Roehrig and Allred (1974), using glucose-6-phosphate dehydrogenase (No. 
G8878. Sigma Chemical, St. Louis, Mo.) and hexokinase 
(No. H5500. Sigma Chemical, St. Louis, Mo.). Briefly, the 
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method involves an exoglucosidase, Amylogucosidase, from 
Aspergillus niger which hydrolyses the -O-D-(1-4) and 
-C-D-(1-6)-linkages of glycogen. The glucose formed is 
Specifically determined with hexokinase and glucose-6- 
phosphate dehydrogenase. The glucose liberated after 
hydrolysis of glycogen is proportional to the increase of 
absorbance measured at 340 nm. Fifty till of sample was 
incubated with 1 mL ATP, NADP, Glucose-6-phosphate 
dehydrogenase buffer and 5 lull hexokinase at 37 C. for 15 
min. Absorbance was measured at 340 nm wavelength, light 
path=1 cm. The muscle glycogen content was calculated 
with the following formula: Glycogen (umol glucose/g wet 
muscle weight)=111.882xabsorbance. 111.882 is the dilu 
tion factor. 
0113 R-Value 
0.114) R-value measures the ratio of hypoxanthine to 
nucleotides, and that ratio is an indicator of the rigor State of 
muscle (Honikel and Fischer, 1977). Duplicate, frozen 
samples (4 g) were homogenized with 10 mL 0.9 M per 
chloric acid in a Waring stainless steel mini blender (Model 
31BL92, Waring Products Division, Dynamics Corporation 
of America, New Hartford, Conn.) for 30 sec. The homo 
genate was filtered through Whatman #1 filter paper. An 
aliquot of 0.1 mL of the filtrate was diluted into 4.9 mL 0.1 
M phosphate buffer, pH 7.0. The absorption at 250 and 260 
nm was measured with phosphate buffer as blank. R-value 
was calculated using the following formula: R-value=Ab 
Sorbance250/Absorbance 260. 
0115 Determination of Nicotinamide-Adenine Dinucle 
otides 
0116 Muscle NAD/NADH metabolism is related to the 
reduction process, muscle color and the process of glyco 
lysis. In the process of glycolysis, NAD is reduced during 
the oxidation of glyceraldehyde 3-phosphate to 1,3 bispho 
sphoglycerate and NADH is oxidized to NAD during the 
reduction of pyruvate to lactate. The inhibition of glycolysis 
postmortem could be expected to alter NAD and NADH 
content depending on the manner in which glycolysis is 
inhibited. Velazco (1998) hypothesized that inhibition of 
enolase by sodium fluoride (NaF) might provoke a final 
reduced state (low NAD/NADH ratio). Results presented 
herein for the method of the invention were unexpected in 
that they do not Support this hypothesis. Faustman and 
Cassens (1991) found that gluteus medius contained less 
NAD and was leSS color-Stable than longissimus muscle. In 
the results presented herein, control Samples had leSS NAD 
content than treated ones, although differences in color were 
insignificant. The leSS intense red color detected in injected 
Samples may reflect a brine injection effect. Martin-Herrera 
(1998) also found that flank muscles marinated with calcium 
fluoride or Sodium fluoride were less red than non-injected 
muscles. 
0117 Nicotinamide-adenine dinucleotide in the oxidated 
state (NAD) and NADH (the reduced state) were determined by a spectrophotometric absorption method (Klingenberg, 
1985), with two different extraction methods. NAD was 
extracted with acid and NADH with alkali, under Suitable 
conditions. 
0118 For NAD extraction, 1 g of powdered, frozen 
sample and 5 mL of 0.6 N perchloric acid were vigorous 
Stirring with a magnetic Stirrer. To remove protein, extracts 
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were centrifuged for 5 min at 3000 to 5000xg. An aliquot of 
1 mL of the Supernatant was neutralized to pH 7.2-7.4 with 
1 N KOH. The reduction of NAD" was quantified by the 
following reaction: Ethanol--NAD's Acetaldehyde-- 
NADH--H". Alcoholdehydrogenase from yeast (No. A3263. 
Sigma Chemical, St. Louis, Mo.) was used to catalyze the 
reaction. The concentration was calculated as the change in 
extinction before and after the enzyme was added at 340 nm 
wavelength, and multiplied by the dilution factor, following 
the formula described by Klingenberg (1985). 
0119) Alkaline extraction of NADH was performed mix 
ing 2 mL of cold alcoholic potassium hydroxide Solution 
(0.5N) with 200-300 mg of frozen tissue with a stirrer. After 
5 min in a 90° C. shake water bath, extracts was neutralized 
by slow addition of triethanolamine-HCL-phosphate mix 
ture (0.5 M triethanolamine; 0.4 M KHPO, 0.1 M 
KHPO) to bring the pH to 7.8. Extracts were placed at 
room temperature for 10 minto allow the denatured protein 
to flocculate, then centrifugation was performed for 5 min at 
20,000 to 40,000xg at 4 C. An aliquot of 1 mL was taken 
immediately for measurements. The lactate dehydrogenase 
(No. L5432. Sigma Chemical, St. Louis, Mo.) reaction was 
used for the determination of NADH, as follows: NADH 
H"+Pyruvatees NAD"+Lactate. 
0120) The quantification of NADH was the same as 
described for NAD. The increase in extinction due to 
addition of lactate dehydrogenase from Skeletal muscle was 
followed. 
0121 Statistical Analysis 
0122) The experimental design was a complete random 
ized design. Data were analyzed by ANOVA with the 
General Linear Model procedure of SAS (SAS, 1995). The 
treatment design was a 3 (muscle type)x5 (treatment) fac 
torial arrangement. The experiment was replicated four 
times. Means were separated using the Least Significant 
Difference procedure (Steel and Torrie, 1980), tested on 
Least Square Means at P-0.05. 
0123 Two models were tested. Model I was analyzed as 
a 3x5 factorial, including data from all muscles (60 obser 
Vations) and independent variables were: muscle type (3), 
treatments (5) and the musclextreatment interaction (3x5 
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factorial arrangement). The model II was a complete ran 
domized design for each individual muscle type (20 obser 
vations) and the independent variable was treatment (5). The 
muscleXtreatment interaction was not significant (P>0.05), 
therefore results from model II were followed. 
Example 2 
Use of Sodium Citrate to Enhance Tenderness and 
Palatability of Pre-Rigor Beef Muscles 
0.124 Experiments were conducted to evaluate the 
response in Warner-Bratzler shear force and consumer 
acceptability of muscles pumped pre-rigor with different 
concentrations of Sodium citrate Solutions, while maintain 
ing Skeletal restraint for 24 hours. 
0.125 Thoracic limbs from 14 steers were chilled on the 
carcass (controls) or removed within 2 hours post-mortem 
and pumped to 10% of muscle weight with water, 200 mM 
or 400 mM sodium citrate solutions. The injections were 
performed at various Sites along the muscle. The control 
remained on the carcass. Muscle pH and temperature were 
measured immediately prior to pumping. Experimental and 
control muscles were chilled at 2 C. for 24 hours. Steaks 
(2.54 cm thick) were removed after 24 hours from the 
Infraspinatus, Supraspinatus and Triceps brachii muscles 
and were either frozen immediately or aged for another 6 
days and then evaluated. A consumer panel evaluated pal 
atability juicineSS, tenderneSS, connective tissue amount, and 
flavor desirability) on Infraspinatus and Triceps brachii 
Steaks using 9-point hedonic Scales (1 being very undesir 
able and 9 being very desirable) for each trait. Warner 
Bratzler shear force values were determined on 1.27 cm 
diameter cores from Steaks that were broiled to an internal 
temperature of 70° C. 
0.126 Treatment with 400 mM sodium citrate improved 
shear force values over the controls at day 1 and day 7 for 
all muscles except the Triceps brachii on day 1 (Table 16). 
TenderneSS ratings followed the same trend, except for the 
Infraspinatus. Connective tissue amount, flavor and juici 
ness of the 400 mM citrate treated-steaks (Infraspinatus and 
Triceps brachii) were rated as more desirable (P<0.10) than 
the controls at day 1 and day 7 (data not shown). 
TABLE 1.5 





Triceps brachi Supraspinatus 
Infraspinatus (ISP TBR SSP 
Treatment d1 d7 d1 d7 d1 d7 
Control 3.61 a,b 3.5Obe 3.71 a 3.59 5.24 4.78 
O mM 3.96 3.79 453b 4.41c 5.12B 4.90 
200 mM 3.57b 3.12b 3.85a 3.57b 409a 3.83 a 
400 mM 3.32 2.79a 3.55a 3.09. 3.91 4.03 
Control 5.41 a,b 5.52a 4.69 4.64 
O mM 4.95b 4.93 3.99 4.13 
200 mM 5.36a,b 5.68a 4.81 
400 mM 5.67a 5.90a 5.25a 5.48 
Control 5.18a; 4.84 5.00a 474. 
O mM 5.02b 4.69 4.58b 4.48 
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TABLE 15-continued 
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Shear force and sensory ratings of muscle iniected with sodium citrate 
Triceps brachi Supraspinatus 
Infraspinatus (ISP TBR SSP 
Trait Treatment d1 d7 d1 d7 
200 mM 5.33a,b 5.35a 5.23a 487a 
400 mM 5.49a 5.41 5.30a 5.18a 
d1 
a,b,cMeans in the same column within each trait with different superscripts differ signifi 
cantly (P<.05) 
*Control versus 400 mM differ significantly at P3.10 
0127 Characteristics of steaks treated with 200 mM 
Sodium citrate were usually between the controls and the 
400 mM concentration. Pumping with water was generally 
detrimental to tenderneSS and palatability. 
0128. These data indicate that a 400 mM sodium citrate 
Solution may be applied to pre-rigor beef muscles (con 
Strained from contraction) to enhance tenderness and palat 
ability. 
0129 Evaluation of Color and Microbial Stability 
0130. These data indicate that sodium citrate-treated 
muscles are Similar in color with untreated controls after two 
days of retail display. (Table 16). They start out darker, but 
quickly come together. 
0131 Table 17 indicates that the three muscles differed in 
their response to the various treatments. Given the differ 
ences in fiber type profile, this is to be expected. In general, 
the 400 mM Sodium citrate caused two of the three muscles 
to be slightly, but significantly, darker than controls (higher 
L* values). In addition, tables 18 and 19 reveal that the 400 
mM-treated Samples has similar a (redness) and b (green/ 
yellow) values after 1 day of retail display, compared to 
untreated controls. 
0132) Microbial stability is reported in table 21. There 
were no differences in initial microbial load among the 
treatments. However, the additional handling needed to 
inject the muscles resulted in greater Overall microbial 
numbers at day 5 than the uninjected control. Of greatest 
interest, however, is that treatment with 400 mM Sodium 
citrate showed no greater microbial growth than the control 
(P>0.05) while the other treatments had greater increases in 
microbial numbers. 
0133) Sarcomere lengths were similar (or longer) for 
treated muscles than for controls (table 20). 
TABLE 16 
Visual Color 
Day Control?carc Control?water 200 mM. NaClt 400 mM NaCit 
O 3.29b 2.90. 3.67 4.10 
1. 3.76b 3.43 3.95b.c 4.24 
2 4.19 3.24a 4.10 4.29b 
3 4.14. 3.38 4.19 4.33b 
4 4.10 3.19 4.14 4.29B 
5 4.43 3.48 4.14 4.29B 
TABLE 16-continued 
Visual Color 
Day Control?carc Control?water 200 mM. NaCit 400 mM NaCit 
*'''Means within the same row that have different superscripts are sig 
nificantly different (p < .05). 
A 5-point scale was used: 1 = Pale cherry red, 3 = Bright cherry red, 5 = 




Muscle Control?carc Control?water 200 mM NaCit 400 mM NaCit 
ISP 42.87a 45.64 43.55 43.19 
SSP 38.80 39.45 36.60 36.02 
TBR 36.99 42.01 38.91 34.92 
*'''Means within the same row that have different superscripts are sig 




Day Control?carc Control?water 200 mM. NaCit 400 mM NaCit 
O 26.64 27.47a 23.92b 23.94 
1. 23.28b 24.56a 23.44a,b 23.33P 
2 21.19 23.12 22.18a,b 21.40 
3 20.23 21.86 20.84a. 20.66 
4 18.64 20.69a 20.11a 19.87a 
5 18.79b 20.32a 20.80 19.73a,b 
*'''Means within the same row that have different superscripts are sig 




Day Control?carc Control?water 200 mM. NaCit 400 mM NaCit 
O 19.68 21:23a 17.37c 17.19e 
1. 19.35 2141 20.13a,b 20.14a,b 
2 18.99 21.32 19.72b 18.55 
3 18.92b 21.05a 19.22b 18.84 
US 2002/0054941 A1 
TABLE 19-continued 
b* Values 
Day Control?carc Control?water 200 mM. NaClt 400 mM NaCit 
4 17.97b 20.33 18.79 18.25 
5 18.90 20.37a 19.90a,b 19.34ab 
''Means within the same row that have different superscripts are sig 
nificantly different (p < .05). 
0137) 
TABLE 2.0 
Sarcomere Length Values 
Muscle Control?carc Control?water 200 mM NaCit 400 mM NaCit 
ISP 1.97a 2.25a 2.04 2.09a 
SSP 2.06 2.76a 2.42a 2.53a 
TBR 2.57a 2.26a 2.35a 2.40a 
*'''Means within the same row that have different superscripts are sig 
nificantly different (p < .05). 
0138) 
TABLE 21 
Logarithmic Microbiological Growth Values 
Muscle Control?carc Control?water 200 mM NaCit 400 mM NaCit 
day O 2.08 2.51 2.58 2.72 
day 5 3.59a 5.7Ob 5.45 5.11b 
differ- 1.50a 3.21b 2.88b 2.40a,b 
eCe. 
''Means within the same row that have different superscripts are sig 
nificantly different (p < .05). 
Example 3 
Preparing the Muscle for Treatment 
0.139. In preparation for treatment of the pre-rigor muscle 
with the compositions of the invention, the muscle may be 
manually or mechanically removed from the Skeleton. Alter 
natively, the entire carcass, or a portion thereof, could be 
treated with the muscle fully or partially attached to the 
skeleton. 
0140 General methods for treatment of muscle may be 
applied before or after application of the invention. Such 
methods might include, but are not limited to, the applica 
tion of refrigeration, freezing, or other methods of tempera 
ture reduction. Steps might also be taken to alter the bio 
chemical State of the muscle, like electrical Stunning of the 
animal, electrical Stimulation of the carcass or muscle, or 
other physical/mechanical manipulation (including tum 
bling and/or massaging with or without vacuum). Addition 
ally or alternatively, it may be desired to reduce muscle size. 
This could occur by grinding, slicing, macerating, chipping, 
flaking, cutting or other conventional methods which could 
occur before, during, or after the above-described treat 
ments. Other general commercial applications may be 
employed, Such as procedures to open the muscle Structure 
through cutting, macerating, puncturing, pumping, extrud 
ing, or Similar Strategies known in the art. 
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0141 Application of Solutions containing water and/or 
other ingredients may also be used to retain, augment, 
enhance or simultaneously improve tenderness. These Solu 
tions may be applied in advance of, in conjunction with, or 
Subsequent to application of the invention. 
Example 4 
Methods of Application 
0142. The compositions of the invention can be applied 
through direct injection into the muscle (pumping). This can 
be done manually or mechanically. Meat treated in Such a 
matter could be expected to gain 3%-40% of its weight 
through Such a method. Typically, the concentration of the 
compositions of the invention is established in part through 
a calculation of the amount of Solution to be pumped into the 
meat and the net gain in weight expected to occur-as 
influenced by Subsequent processing factors like dwell time, 
drain time, packaging, cooking or other factors. Since the 
concentration of the compositions of the invention which 
can be used in a given manufacture of meat or meat product 
can vary considerably with the Specific pre-treatment 
method of application/post-application processing of the 
manufacture, the range of concentrations used in the method 
of the instant invention include from about 0.1% to about 
40%. 
0.143 An alternative or Supplement to pumping is mari 
nation of the meat in a Solution containing Some or all of the 
compositions of the invention. This can occur in conjunction 
With other ingredients, like Salt and phosphates, among 
others. The marination (or steeping) can occur for a definite 
period of time or indefinitely and may or may not be 
programmed for a particular temperature and pressure. 
0144. Another technique to deliver the compositions of 
the invention to the muscle would be by artery or vein 
injection, whereby the vascular System of the muscle is used 
to help distribute the Solution containing the invention 
(alone or in combination with others) into the muscle. This 
approach can include infusion into the animal body. A 
high-pressure spray and/or a vacuum system may be part of 
the delivery mechanism. 
Example 5 
Post-Application Processing 
0.145) A number of post-application processing steps may 
be applied individually or in combination to meat treated 
with the compositions of the invention to retain or enhance 
the effects thereof. A time delay after treatment can be 
implemented for a number of reasons, including to retain or 
enhance effects of the invention, provide time for additional 
processing procedures, and/or for distribution. This time 
delay can range in duration from minutes to dayS. Tumbling 
and/or massaging (ranging from minutes to Several hours) 
can be used, alone or in conjunction with other physical/ 
mechanical manipulation Such as described in Examples 3 
and 4 and a post-treatment marinade (as described in 
Example 4) may be applied. Additionally, temperature 
manipulation can be applied. This could range from freezing 
and refrigeration to pre-cooking or cooking. A combination 
of these Strategies would likely be used. 
0146 Products treated with the invention can be pack 
aged in a variety of ways. It is possible for features of the 
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packaging to retain or enhance application and/or effective 
neSS of the invention. For example, Vacuum packaging can 
enhance uptake of a marinade. The package can help ensure 
the added Solution remains within the meat (rather than 
draining out of the muscle). Some packages are designed for 
cooking of product within (e.g., bone-in-the-bag package) 
and thus can enhance effectiveness as previously described. 
0.147. Other post-treatment procedures can include size 
reduction (as described in Example 3) and/or combination 
with other common processing Steps, Such as treatment with 
other ingredients. 
Example 6 
Enhancing Tenderness of Skeletal Muscle from 
Other Species 
0.148. From a manufacturing perspective, different 
muscles types behave in a similar manner. For example, 
Virtually all of the meat processing equipment in the industry 
works on meat from any species (with the possible exception 
of fish). The grinders, mixers, Stuffers, and tumblers used in 
a poultry meat operation are often identical to equipment 
used for beef or pork. Thus, it is appropriate to extrapolate 
these results to all Striated, skeletal muscle. Biochemistry of 
muscle is consistent acroSS Species to Such an extent that the 
focus is on the few subtle differences rather than the simi 
larities among muscle types. The post-mortem biochemistry 
of all striated, Skeletal muscle is similar. They rely on 
glycolysis (the degradation of endogenous glycogen) to 
generate energy (ATP) within the muscle during rigor, 
thereby producing lactic acid and dropping muscle pH. The 
Same biological Structures exist-at both the cellular as well 
as the tissue level. Given the common biochemistry of 
striated Skeletal muscles, Similar results are to be expected 
with Skeletal muscle, including muscle of pork, lamb, poul 
try, bison and liama. 
0149 While the invention has been disclosed in this 
patent application by reference to the details of preferred 
embodiments of the invention, it is to be understood that the 
disclosure is intended in an illustrative rather than in a 
limiting Sense, as it is contemplated that modifications will 
readily occur to those skilled in the art, within the spirit of 
the invention and the Scope of the appended claims. 
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We claim: 
1. A method of enhancing tenderness of animal meat 
comprising: 
a) Slaughter and eviscerate said animal, 
b) excise pre-rigor Skeletal muscle of Said animal, 
c) apply a composition to said excised skeletal muscle, 
wherein Said application comprises injection of Said com 
position into the skeletal muscle and wherein Said 
composition comprises Solutions of compounds 
Selected from the group consisting of citric acid, a Salt 
of citric acid, glucose, Sodium oxalate, oxamic acid, 
Sodium acetate and combinations thereof. 
2. The method of claim 1, wherein Said compound is in 
Solution at a concentration of about 0.1% to about 10%. 
3. The method of claim 1, wherein said compound is in 
Solution at a concentration of about 0.5% to about 8%. 
4. The method of claim 1, wherein said compound is in 
Solution at a concentration of about 0.5% to about 5%. 
5. The method of claim 2, wherein the weight of said 
solution is equal to about 3% to about 40% of the weight of 
Said excised skeletal muscle. 
6. The method of claim 2, wherein the weight of said 
solution is equal to about 3% to about 20% of the weight of 
Said excised skeletal muscle. 
7. The method of claim 1, wherein said composition is 
citric acid. 
8. The method of claim 1, wherein said compound is a salt 
of citric acid. 
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9. The method of claim 8, wherein said compound is 
Sodium citrate. 
10. The method of claim 1, wherein said compound is 
glucose. 
11. The method of claim 1, wherein said compound is 
Sodium oxalate. 
12. The method of claim 1, wherein said compound is 
oxamic acid. 
13. The method of claim 1, wherein said compound is 
Sodium acetate. 
14. The method of claim 1, wherein said animal meat is 
Selected from the group consisting of beef, pork, lamb, 
poultry, deer, bison and llama. 
15. A method enhancing tenderneSS of animal meat com 
prising: 
a) Slaughter and eviscerate said animal, 
b) maintain skeletal restraint of pre-rigor Skeletal muscle 
of Said animal, 
c) apply a composition to said pre-rigor Skeletal muscle, 
d) excise said skeletal muscle, 
wherein Said application comprises injection of Said com 
position into the pre-rigor Skeletal muscle, and wherein 
Said composition comprises Solutions of compounds 
Selected from the group consisting of citric acid, a Salt 
of citric acid, glucose, Sodium oxalate, oxamic acid, 
Sodium acetate and combinations thereof. 
16. The method of claim 15, wherein said compound is 
included in the Solution at a concentration of about 0.1% to 
about 10%. 
17. The method of claim 15, wherein said compound is 
included in the Solution at a concentration of about 0.5% to 
about 8%. 
18. The method of claim 15, wherein said compound is 
included in the Solution at a concentration of about 0.5% to 
about 5%. 
19. The method of claim 16, wherein the weight of said 
solution is equal to about 3% to about 40% of the weight of 
Said excised skeletal muscle. 
20. The method of claim 16, wherein the weight of said 
solution is equal to about 3% to about 20% of the weight of 
Said excised skeletal muscle. 
21. The method of claim 15, wherein said composition is 
citric acid. 
22. The method of claim 15, wherein said compound is a 
Salt of citric acid. 
23. The method of claim 22, wherein said compound is 
Sodium citrate. 
24. The method of claim 15, wherein said compound is 
glucose. 
25. The method of claim 15, wherein said compound is 
Sodium oxalate. 
26. The method of claim 15, wherein said compound is 
oxamic acid. 
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27. The method of claim 15, wherein said compound is 
Sodium acetate. 
28. The method of claim 1, wherein said animal meat is 
Selected from the group consisting of beef, pork, lamb, 
poultry, deer, bison and llama. 
29. A method of enhancing tenderness of animal meat 
comprising: 
a) Slaughter and eviscerate said animal, 
b) excise pre-rigor Skeletal muscle of Said animal, 
c) apply a composition to said excised skeletal muscle, 
wherein Said application comprises marination in Said 
composition, and wherein Said composition comprises 
Solutions of compounds Selected from the group con 
Sisting of citric acid, a Salt of citric acid, glucose, 
Sodium oxalate, oxamic acid, Sodium acetate and com 
binations thereof. 
30. The method of claim 29, wherein said compound is in 
Solution at a concentration of about 0.1% to about 20%. 
31. The method of claim 29, wherein said compound is in 
Solution at a concentration of about 0.5% to about 15%. 
32. The method of claim 29, wherein said composition is 
citric acid. 
33. The method of claim 29, wherein said compound is a 
Salt of citric acid. 
34. The method of claim 33, wherein said compound is 
Sodium citrate. 
35. The method of claim 29, wherein said compound is 
glucose. 
36. The method of claim 29, wherein said compound is 
Sodium oxalate. 
37. The method of claim 29, wherein said compound is 
oxamic acid. 
38. The method of claim 29, wherein said compound is 
Sodium acetate. 
39. The method of claim 29, wherein said animal meat is 
Selected from the group consisting of beef, pork, lamb, 
poultry, deer, bison and llama. 
40. The method of claim 1, wherein said injection com 
prises direct injection into the Said excised skeletal muscle. 
41. The method of claim 1, wherein said injection com 
prises methods Selected from the group consisting of injec 
tion into a vein, into an artery, by perfusion and combina 
tions thereof. 
42. The method of claim 15, wherein said injection 
comprises direct injection into the Said excised skeletal 
muscle. 
43. The method of claim 15, wherein said injection 
comprises methods Selected from the group consisting of 
injection into a vein, into an artery, by perfusion and 
combinations thereof. 
44. The meat prepared by the method of claim 1. 
45. The meat prepared by the method of claim 15. 
46. The meat prepared by the method of claim 29. 
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